Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sorghum bicolor subsp. drummondii pollen, commonly known as Sudan grass pollen, is utilized as an allergenic extract for both diagnostic and therapeutic purposes. In clinical practice, it is employed in skin prick testing to confirm hypersensitivity in patients presenting with seasonal allergic rhinitis, conjunctivitis, or asthma. For treatment, it is used in allergen-specific immunotherapy (AIT), where increasing doses of the extract are administered subcutaneously to induce immunological tolerance. This process involves shifting the immune response from a Th2-dominated profile to a Th1 and regulatory T-cell (Treg) response, leading to the production of blocking IgG4 antibodies and a reduction in allergen-specific IgE-mediated mast cell degranulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sorghum bicolor subsp. drummondii pollen.